Safety and Feasibility of Pressurised Intra-Peritoneal Aerosol Chemotherapy (PIPAC) in Patients with End-stage Peritoneal Cancer of Unknown Origin (CUP)

Safety and Feasibility of Pressurised Intra-Peritoneal Aerosol Chemotherapy (PIPAC) in Patients with End-stage Peritoneal Cancer of Unknown Origin (CUP)

Dr. med. Fabian Kockelmann

Prof. Dr. med. Urs Pabst-Giger (Projektleiter)

Prof. Dr. med. PhD Mehdi Ouaissi

Prof. Dr. med. Jürgen Zieren

2025-2026

Department of Surgery, Städtisches Krankenhaus Dortmund, Germany

Department of Digestive, Oncological, Endocrine and Hepatobiliary Surgery and Liver Transplantation, University Hospital Trousseau, CHU de Tours, France

Retrospective analysis of a single centre, prospectively maintained database of PIPAC CUP patients. Safety, feasibility and oncological outcome

AT-ROVL